Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8635 W 3rd St
Ste 1070
Los Angeles, CA 90048Phone+1 310-423-4700Fax+1 310-423-4711
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2003 - 2004
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Urologic Surgical Oncology, 2002 - 2003
- University of ChicagoResidency, Urology, 1996 - 2002
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1996
- University of MichiganB.S., 1989 - 1992
Certifications & Licensure
- CA State Medical License 2002 - 2025
- NY State Medical License 2004 - 2019
- IL State Medical License 2001 - 2002
- American Board of Urology Urology
Awards, Honors, & Recognition
- Homer and Gloria Harvey Family Chair in Urologic Oncology in Honor of Stuart Friedman, M.D. Cedars Sinai Medical Center, 2018
- 1st place essay- national meeting American Urologic Association, 2010
- Winnick research award 2010
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsPAK4 inhibition improves PD1 blockade immunotherapy in prostate cancer by increasing immune infiltration.Shengchen Su, Sungyong You, Yanping Wang, Patrick Tamukong, Michael J Quist
Cancer Letters. 2023-02-28 - 97 citationsMitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.Hyung L. Kim, Donald J. Vander Griend, Ximing J. Yang, David A. Benson, Zita Dubauskas
Cancer Research. 2001-04-01 - 54 citationsA comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models.Hao Zhang, Dror Berel, Yanping Wang, Ping Li, Neil A. Bhowmick
Plos One. 2013-01-22
Journal Articles
- Hao Zhang H., Berel, D., Wang, Y., Figlin, R.A., Kim, H.L., PlosOne, 1/1/2013
- Brewer K., O'Malley R.L., Hayn M., Safwat M.W., Kim H.L. Underwood W., Schwaab T., J Endourol, 3/1/2012
- O'Malley R.L., Hayn M.H., Hellenthal N.J., Kim H.L., Underwood W., Schwaab T., Can J Urol, 2/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Join now to see all
Lectures
- Join now to see all
Press Mentions
- Prognostic Value of Soluble ST2 and Soluble LR11 on Mortality and Cardiovascular Events in Peritoneal Dialysis PatientsJune 15th, 2020
- Presents State of Science SummitFebruary 21st, 2018
Grant Support
- R01NCI/NHI2008–Present
- K23NCI/NIH2007–2012
Professional Memberships
- Member
- Society of Urologic OncologyMember
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: